The group's principal activity is to develop proprietary scientific technology for the curing of starcured (TM) tobacco so as to reduce the formation of carcinogenic toxins present in tobacco and tobacco smoke. The group sells, markets and develops less toxic and harmful tobacco products and discount cigarettes with activated charcoal filters. The group's research and development activities include reducing the various health hazards associated with the use of smoked and smokeless tobacco products. The group's operating segments are discount cigarettes and smokeless tobacco products and leaf tobacco.
